Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Apple
AAPL
|
+$3.09B |
| 2 |
Microsoft
MSFT
|
+$2.42B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.74B |
| 5 |
Amazon
AMZN
|
+$1.27B |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.54B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$549M |
| 3 |
Technology Select Sector SPDR Fund
XLK
|
+$452M |
| 4 |
Stellantis
STLA
|
+$326M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$239M |
Sector Composition
| 1 | Technology | 29.05% |
| 2 | Healthcare | 11.56% |
| 3 | Financials | 10.8% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Ubiquiti
UI
$36.7B
| $48K | ﹤0.01% |
270
-51
| -16% | -$9.07K |
|
3527
Q32 Bio
QTTB
$21.6M
| $48K | ﹤0.01% |
2,983
| – | – |
|
|
OSG
3528
DELISTED
Overseas Shipholding Group Inc.
OSG
| $48K | ﹤0.01% |
11,566
-23,090
| -67% | -$95.8K |
|
3529
Angi Inc
ANGI
$762M
| $47K | ﹤0.01% |
1,421
+1,416
| +28,320% | +$46.8K |
|
3530
Asure Software
ASUR
$219M
| $47K | ﹤0.01% |
3,830
-22,427
| -85% | -$275K |
|
3531
Carisma Therapeutics
CARM
$16.6M
| $47K | ﹤0.01% |
+5,312
| New | +$47K |
|
3532
American Express Global Business Travel
GBTG
$4.23B
| $47K | ﹤0.01% |
+6,464
| New | +$47K |
|
3533
Structure Therapeutics
GPCR
$1.21B
| $47K | ﹤0.01% |
+1,132
| New | +$47K |
|
3534
Mineralys Therapeutics
MLYS
$2.92B
| $47K | ﹤0.01% |
2,778
-9,758
| -78% | -$165K |
|
3535
OptimizeRx
OPRX
$320M
| $47K | ﹤0.01% |
3,305
-5,137
| -61% | -$73.1K |
|
3536
Organogenesis Holdings
ORGO
$609M
| $47K | ﹤0.01% |
13,992
-88,836
| -86% | -$298K |
|
3537
Oramed Pharmaceuticals
ORMP
$94.3M
| $47K | ﹤0.01% |
13,239
-7,410
| -36% | -$26.3K |
|
3538
Red River Bancshares
RRBI
$427M
| $47K | ﹤0.01% |
961
-1,245
| -56% | -$60.9K |
|
3539
Spok Holdings
SPOK
$355M
| $47K | ﹤0.01% |
3,552
-59,095
| -94% | -$782K |
|
3540
Willdan Group
WLDN
$1.47B
| $47K | ﹤0.01% |
2,427
-3,491
| -59% | -$67.6K |
|
|
BCEL
3541
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $47K | ﹤0.01% |
47,487
| – | – |
|
|
ADAP
3542
Adaptimmune Therapeutics
ADAP
$13.1M
| $46K | ﹤0.01% |
+50,061
| New | +$46K |
|
3543
Culp
CULP
$59.4M
| $46K | ﹤0.01% |
9,228
| – | – |
|
3544
Vertical Aerospace
EVTL
$476M
| $46K | ﹤0.01% |
+2,351
| New | +$46K |
|
3545
SPDR S&P Kensho Future Security ETF
FITE
$82.8M
| $46K | ﹤0.01% |
946
| – | – |
|
3546
Full House Resorts
FLL
$122M
| $46K | ﹤0.01% |
6,920
-9,738
| -58% | -$64.7K |
|
3547
Potbelly
PBPB
$514M
| $46K | ﹤0.01% |
5,229
-5,253
| -50% | -$46.2K |
|
3548
CPI Card Group
PMTS
$164M
| $46K | ﹤0.01% |
1,977
-5,514
| -74% | -$128K |
|
3549
Red Violet
RDVT
$689M
| $46K | ﹤0.01% |
2,227
-2,711
| -55% | -$56K |
|
3550
USA Compression Partners
USAC
$2.84B
| $46K | ﹤0.01% |
2,336
-551
| -19% | -$10.9K |
|